Clincosm LogoSign in Get a demo

acquired thrombotic thrombocytopenic purpura

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Caplacizumab in Treatment of Acquired Thrombotic

Not yet recruiting
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Cologne, Germany
    University Hospital of Cologne
May 25, 2023

Improvement of Immunologic and Molecular Techniques for

Not yet recruiting
  • Acquired Thrombotic Thrombocytopenic Purpura
  • ADAMTS13 Activity Assays
  • (no location specified)
May 26, 2022

Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Standard of Care)

Completed
Has Results
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Caplacizumab
  • Standard of Care
  • Saint Louis, Missouri
  • +44 more
Mar 21, 2022

Efficiency of Caplacizumab in the Treatment of aTTP

Recruiting
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Cologne, Germany
    University Hospital of Cologne
Dec 28, 2021

Acquired Thrombotic Thrombocytopenic Purpura Trial in Shanghai (Anfibatide, Placebos)

Unknown status
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Shanghai, Shanghai, China
    Shanghai Ruijing Hospital
Jul 15, 2019

Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Placebo)

Completed
Has Results
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Caplacizumab
  • Placebo
  • Los Angeles, California
  • +50 more
May 6, 2019

Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Placebo)

Completed
Has Results
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Caplacizumab
  • Placebo
  • Birmingham, Alabama
  • +100 more
May 21, 2019